Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

David Cooke
Dr. David Tom Cooke, M.D., F.A.C.S., is a thoracic oncologist and surgeon who specializes in lung cancer, esophageal cancer and robotic surgery at UC Davis Medical Center.
How has the lung cancer space evolved since you entered the field? 

The field has evolved greatly. When I was a medical student at Harvard Medical School, much of thoracic surgery was performed with large incisions. We had very little resources to improve patient outcomes. Now, 80 percent of my surgeries for early-stage lung cancer are performed minimally invasively with small incisions and a robot. We have personalized medicine where we study patients’ tumors, identify unique signatures (mutations) and treat them either before surgery or after surgery with targeted therapy. In addition, we have immunotherapy to increase the chance for cure. These are all amazing innovations that have occurred within the last decade.

What are the benefits of robotic surgery compared to other forms of tumor removal surgery?

Robotic lung surgery has led to less blood loss during surgery, improved pain after surgery, shorter hospital stays and return to work and activities of daily living faster for our [lung] patients. In addition, minimally invasive surgery leads to a better chance of survival after surgery compared to traditional open surgery with a large incision. Almost anyone who’s a candidate for lung cancer surgery is a candidate for robotic surgery.

What does your patient-centric care look like in daily interactions with patients?

I believe in patient-centered and human-centered care. This means understanding a patient’s lung cancer journey from their perspective. That includes acknowledging the anxiety a patient may feel when they are diagnosed, their concerns about being treated and the outcomes that are most important to them, other than surviving lung cancer, after treatment. This includes looking at their whole needs. It starts with proper informed consent about surgery, including their risk for chronic pain after surgery. It includes having them evaluated by our social workers to help them manage diagnosis-related anxiety and stress

What are some of your findings within the lung cancer space regarding racial differences? 

Lung cancer is the number one cancer killer for Black/African Americans. Black/African American males are more likely to die from lung cancer than their white counterparts. In addition, Black/African Americans are less likely to undergo surgery for early stage lung cancer. It is imperative that we eliminate these disparities, and this includes offering curative potential surgical resection for our underserved communities when diagnosed. That also means offering innovative, next-level care including robotic lung cancer surgery. It is critical that underserved communities get access to these lifesaving innovations. 

If a surgeon doesn’t consider health care disparities in their assessments and is not skilled in culturally competent communication with the communities they serve, then they are not doing their job.

How did #LCSM form and why did you feel it was a necessary network?

The #LCSM movement is a patient-focused collaborative based in social media started by me and a medical oncologist, a lung cancer survivor and two advocates whose mothers had passed away from lung cancer. We came together because we found there was a lack of community online within the lung cancer space. Through this, #LCSM Chat was born. Primarily Twitter-based, this movement has had over a billion impressions, has been adopted by multiple different stakeholders including the National Cancer Institute and has been featured in the New York Times. The creation of this supportive community, grounded in evidence-based medicine, is one of my greatest achievements.

How important is surgery in lung cancer cases?

It is important to understand that surgery is the standard of care treatment and best chance for cure for patients with early stage lung cancer. Modern surgeons have adopted minimally invasive techniques, including robotics, to maximize the positive outcomes for our patients. Despite this, surgery is underutilized in some patient populations and underserved communities. Patients should be empowered to seek out expert opinions on their cancer care.

More
articles

DANIEL MULROONEY ST JUDES
Ask the Doctor

Ask the Doctor

Dr. Daniel Mulrooney of St. Jude Children’s Research Hospital in Memphis, Tennessee answers your questions about childhood cancer and survivorship.

Read More »
HEAD SCARVES
Fashion

Head Scarves

You never had a choice in your diagnosis, but that doesn’t mean your style must go out the window.

Read More »
MANDI CHAMBLESS
(Y)our Stories

cW Slice of Life: “Tomorrow I’ll Know”

In this new series called cW: Slices of Life, check out the journeys of cancer warriors who are taking things day by day. Read on for the first in a three-part story titled “Tomorrow I’ll Know” by Mandi Chambless.

Read More »
BRUSHES WITH CANCER
(Y)our Stories

The Bigger Picture

Art speaks louder than words in Twist Out Cancer’s Brushes with Cancer program that utilizes artists to paint a picture of the relationship individuals have with cancer.

Read More »
COVID LUNG CANCER
Innovations & Research

Breathing Uneasy

Cancer warriors and thrivers may be more susceptible to contracting the novel coronavirus and developing severe complications, especially if there is a history of lung-specific illnesses like mesothelioma.

Read More »